Dr. Hermes is a researcher and educator working at the VA Connecticut Healthcare System who investigates trends in mental healthcare in large healthcare organizations such as the Veterans Health Administration. Along with investigating recent trends in VA mental healthcare utilization, he is interested in evaluating current approaches to the use of pharmacologic and non-pharmacologic therapies in real-world clinical settings as well as the implementation and evaluation of novel treatments.
His recent work has focused on assessing how providers use pharmacologic agents, such as second-generation antipsychotics and sedative-hypnotics in real-world clinical practice, especially in contexts where use may be complicated by side-effects, such as obesity, or driven by less well-documented clinical problems such as insomnia. The recent surge in the development of computer-based therapies has provided Dr. Hermes with the opportunity to evaluate the implementation and outcomes of this novel therapeutic platform, specifically those programs focused on treating insomnia, as a proxy for other computer-based therapies, and as a potential augmentation or substitute to pharmacologic treatment.
- Hermes EDA, Sernyak M, Rosenheck R. Use of Second Generation Antipsychotics for Sleep and Sedation: A Provider Survey. Sleep 2013; 36(4): 597-600. PMID:23565006
- Hermes EDA, Sernyak M, Rosenheck R. Prescription of Second-Generation Antipsychotics: Responding to Treatment Risk in Real World Practice Psychiatric Services 2012; release ahead of print. PMID: 23241613
- Hermes EDA, Sokoloff D, Rosenheck R. Minimum Clinically Important Difference In The Positive And Negative Syndrome Scale Using Data From The CATIE Schizophrenia Trial. Journal of Clinical Psychiatry 2012; 73(4):526-33. PMID: 22579152
- Hermes EDA, Rosenheck R, Desai R, Fontana A. Recent Trends in The Treatment Of Posttraumatic Stress Disorder And Other Mental Health Disorders In The Veteran Health Administration. Psychiatric Services 2012; 63(5):471-76. PMID: 22422018